RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
+71.55%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$381M
AUM Growth
+$381M
(+144%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
43.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$164M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 75.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1
DELISTED
Epizyme, Inc
EPZM
| $164M | 37.08% |
+6,666,667
| New | +$164M |
|
|
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $115M | 25.98% |
2,111,111
| – | – |
|
|
IMMU
3
DELISTED
Immunomedics Inc
IMMU
| $92.5M | 20.92% |
4,373,178
| – | – |
|
4
Cytokinetics
CYTK
$4.23B
| $9.29M | 2.1% |
875,656
| – | – |
|
|
VIRX
5
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $44K | 0.01% |
129,517
| – | – |
|